Emily Pittman, PhD

Program Manager
UC San Diego Moores Cancer Center
La Jolla, California, United States

Disclosure information not submitted.

Presentation(s):

• Paper 83 - AN OPEN-LABEL, PHASE II EFFICACY STUDY OF TEMOZOLOMIDE IN ADVANCED SUCCINATE DEHYDROGENASE-MUTANT/DEFICIENT GASTROINTESTINAL STROMAL TUMOR

  Saturday, November 4, 2023
  3:00 PM – 4:00 PM